Missouri bills · 2026 Regular Session
Missouri HB 2081
Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Ben Keathley (Republican)
Cosponsors (1)
- Bob Titus (Republican)
Summary
No official summary is available for this bill.
Latest action(May 15, 2026): Referred: Emerging Issues(H)
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- May 15, 2026 · House
Referred: Emerging Issues(H) - Jan 8, 2026 · House
Read Second Time (H) - Jan 7, 2026 · House
Read First Time (H) - Dec 1, 2025 · House
Prefiled (H)